{"entity":{"type":"insider","cik":"0001314703","url":"/insider/0001314703","json_url":"/insider/0001314703.json","name":"Scale Venture Partners II, LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":122,"n_filings":10,"first":"2007-11-16","last":"2011-09-22","span_basis":"filed_date"},"name_variants":[{"name":"Scale Venture Partners II, LP","source":"filing","n_filings":10,"first_seen":"2007-11-16","last_seen":"2011-09-22"}],"transactions":[{"id":9009256,"accession":"0001209191-11-048745","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-048745","line_url":"/filing/0001209191-11-048745#line-1","is_derivative":false,"issuer_cik":"0001266275","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001266275","owner_cik":null,"owner_name":"MITCHELL KATE; O'Driscoll Rory; Wienbar Sharon L; Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"MITCHELL KATE","owner_url":null,"role":"Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":2500000.0,"total_display":"2,500,000.00","total_whole":"2,500,000","shares_owned_after":5321546.0,"shares_owned_after_display":"5,321,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-21","filed_date":"2011-09-22","scope":"insider"},{"id":9103806,"accession":"0001209191-11-042516","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-11-042516","line_url":"/filing/0001209191-11-042516#line-4","is_derivative":false,"issuer_cik":"0001266275","issuer_name":"HORIZON PHARMA, INC.","issuer_ticker":"HZNP","issuer_name_source":null,"issuer_url":"/issuer/0001266275","owner_cik":null,"owner_name":"Wienbar Sharon L; Scale Venture Partners II, LP; MITCHELL KATE; O'Driscoll Rory; Scale Venture Management II, LLC","owner_display_name":"Wienbar Sharon L","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":315946.0,"shares_display":"315,946","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":2843514.0,"total_display":"2,843,514.00","total_whole":"2,843,514","shares_owned_after":2204465.0,"shares_owned_after_display":"2,204,465","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-02","filed_date":"2011-08-04","scope":"insider"},{"id":7332439,"accession":"0001209191-10-057213","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-10-057213","line_url":"/filing/0001209191-10-057213#line-4","is_derivative":false,"issuer_cik":"0001266275","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001266275","owner_cik":null,"owner_name":"Wienbar Sharon L; O'Driscoll Rory; Scale Venture Management II, LLC; MITCHELL KATE; Brooks Mark J; Scale Venture Partners II, LP","owner_display_name":"Wienbar Sharon L","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":4071546.0,"shares_owned_after_display":"4,071,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-29","scope":"insider"},{"id":7332433,"accession":"0001209191-10-057213","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-057213","line_url":"/filing/0001209191-10-057213#line-1","is_derivative":false,"issuer_cik":"0001266275","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001266275","owner_cik":null,"owner_name":"Wienbar Sharon L; O'Driscoll Rory; Scale Venture Management II, LLC; MITCHELL KATE; Brooks Mark J; Scale Venture Partners II, LP","owner_display_name":"Wienbar Sharon L","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":589645.0,"shares_display":"589,645","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":2358580.0,"total_display":"2,358,580.00","total_whole":"2,358,580","shares_owned_after":2821546.0,"shares_owned_after_display":"2,821,546","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-26","filed_date":"2010-11-29","scope":"insider"},{"id":7354553,"accession":"0001209191-07-065805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-065805","line_url":"/filing/0001209191-07-065805#line-1","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Management II, LLC; Scale Venture Partners II, LP","owner_display_name":"Scale Venture Management II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","total_whole":"1,500","shares_owned_after":2717445.0,"shares_owned_after_display":"2,717,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-21","filed_date":"2007-11-21","scope":"insider"},{"id":7214439,"accession":"0001209191-07-065504","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-07-065504","line_url":"/filing/0001209191-07-065504#line-8","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Management II, LLC; Scale Venture Partners II, LP","owner_display_name":"Scale Venture Management II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":9000.0,"total_display":"9,000.00","total_whole":"9,000","shares_owned_after":2717545.0,"shares_owned_after_display":"2,717,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-20","filed_date":"2007-11-20","scope":"insider"},{"id":7214437,"accession":"0001209191-07-065504","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-07-065504","line_url":"/filing/0001209191-07-065504","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Management II, LLC; Scale Venture Partners II, LP","owner_display_name":"Scale Venture Management II, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2200.0,"shares_display":"2,200","price_per_share":15.027536363636363,"price_display":"15.03","price_state":"stated","total_value":33060.58,"total_display":"33,060.58","total_whole":"33,061","shares_owned_after":2718545.0,"shares_owned_after_display":"2,718,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-19","filed_date":"2007-11-20","scope":"insider","n_lines":7},{"id":8038625,"accession":"0001209191-07-065220","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-07-065220","line_url":"/filing/0001209191-07-065220","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16142.0,"shares_display":"16,142","price_per_share":15.529793643910295,"price_display":"15.53","price_state":"stated","total_value":250681.929,"total_display":"250,681.93","total_whole":"250,682","shares_owned_after":2726691.0,"shares_owned_after_display":"2,726,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider","n_lines":16},{"id":7836680,"accession":"0001209191-07-065219","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-30","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3900.0,"shares_display":"3,900","price_per_share":15.6,"price_display":"15.60","price_state":"stated","total_value":60840.0,"total_display":"60,840.00","total_whole":"60,840","shares_owned_after":2737487.0,"shares_owned_after_display":"2,737,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836677,"accession":"0001209191-07-065219","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-29","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":15.6054,"price_display":"15.61","price_state":"stated","total_value":39013.5,"total_display":"39,013.50","total_whole":"39,014","shares_owned_after":2741387.0,"shares_owned_after_display":"2,741,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836674,"accession":"0001209191-07-065219","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-28","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1986.0,"shares_display":"1,986","price_per_share":15.6209,"price_display":"15.62","price_state":"stated","total_value":31023.1074,"total_display":"31,023.11","total_whole":"31,023","shares_owned_after":2747801.0,"shares_owned_after_display":"2,747,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836672,"accession":"0001209191-07-065219","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-27","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1800.0,"shares_display":"1,800","price_per_share":15.65,"price_display":"15.65","price_state":"stated","total_value":28170.0,"total_display":"28,170.00","total_whole":"28,170","shares_owned_after":2752902.0,"shares_owned_after_display":"2,752,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836669,"accession":"0001209191-07-065219","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-26","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1615.0,"shares_display":"1,615","price_per_share":15.64,"price_display":"15.64","price_state":"stated","total_value":25258.6,"total_display":"25,258.60","total_whole":"25,259","shares_owned_after":2751287.0,"shares_owned_after_display":"2,751,287","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836666,"accession":"0001209191-07-065219","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-25","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1600.0,"shares_display":"1,600","price_per_share":15.67,"price_display":"15.67","price_state":"stated","total_value":25072.0,"total_display":"25,072.00","total_whole":"25,072","shares_owned_after":2755602.0,"shares_owned_after_display":"2,755,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836660,"accession":"0001209191-07-065219","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-24","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":15.63,"price_display":"15.63","price_state":"stated","total_value":23445.0,"total_display":"23,445.00","total_whole":"23,445","shares_owned_after":2749787.0,"shares_owned_after_display":"2,749,787","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836657,"accession":"0001209191-07-065219","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-23","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400.0,"shares_display":"1,400","price_per_share":15.61,"price_display":"15.61","price_state":"stated","total_value":21854.0,"total_display":"21,854.00","total_whole":"21,854","shares_owned_after":2745201.0,"shares_owned_after_display":"2,745,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836653,"accession":"0001209191-07-065219","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-22","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1314.0,"shares_display":"1,314","price_per_share":15.6078,"price_display":"15.61","price_state":"stated","total_value":20508.6492,"total_display":"20,508.65","total_whole":"20,509","shares_owned_after":2743887.0,"shares_owned_after_display":"2,743,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836649,"accession":"0001209191-07-065219","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-21","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":15.68,"price_display":"15.68","price_state":"stated","total_value":18816.0,"total_display":"18,816.00","total_whole":"18,816","shares_owned_after":2757202.0,"shares_owned_after_display":"2,757,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836644,"accession":"0001209191-07-065219","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-20","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200.0,"shares_display":"1,200","price_per_share":15.62,"price_display":"15.62","price_state":"stated","total_value":18744.0,"total_display":"18,744.00","total_whole":"18,744","shares_owned_after":2746601.0,"shares_owned_after_display":"2,746,601","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836636,"accession":"0001209191-07-065219","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-19","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":15.59,"price_display":"15.59","price_state":"stated","total_value":15590.0,"total_display":"15,590.00","total_whole":"15,590","shares_owned_after":2736487.0,"shares_owned_after_display":"2,736,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836632,"accession":"0001209191-07-065219","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-18","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":15.69,"price_display":"15.69","price_state":"stated","total_value":14121.0,"total_display":"14,121.00","total_whole":"14,121","shares_owned_after":2758402.0,"shares_owned_after_display":"2,758,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836627,"accession":"0001209191-07-065219","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-17","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":15.66,"price_display":"15.66","price_state":"stated","total_value":14094.0,"total_display":"14,094.00","total_whole":"14,094","shares_owned_after":2754702.0,"shares_owned_after_display":"2,754,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836623,"accession":"0001209191-07-065219","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-16","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":15.8,"price_display":"15.80","price_state":"stated","total_value":12640.0,"total_display":"12,640.00","total_whole":"12,640","shares_owned_after":2764202.0,"shares_owned_after_display":"2,764,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836619,"accession":"0001209191-07-065219","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-15","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":15.77,"price_display":"15.77","price_state":"stated","total_value":12616.0,"total_display":"12,616.00","total_whole":"12,616","shares_owned_after":2762302.0,"shares_owned_after_display":"2,762,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836615,"accession":"0001209191-07-065219","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-14","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":15.75,"price_display":"15.75","price_state":"stated","total_value":11025.0,"total_display":"11,025.00","total_whole":"11,025","shares_owned_after":2761602.0,"shares_owned_after_display":"2,761,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836611,"accession":"0001209191-07-065219","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-13","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":15.71,"price_display":"15.71","price_state":"stated","total_value":10997.0,"total_display":"10,997.00","total_whole":"10,997","shares_owned_after":2759602.0,"shares_owned_after_display":"2,759,602","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836607,"accession":"0001209191-07-065219","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-12","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":604.0,"shares_display":"604","price_per_share":15.82,"price_display":"15.82","price_state":"stated","total_value":9555.28,"total_display":"9,555.28","total_whole":"9,555","shares_owned_after":2765202.0,"shares_owned_after_display":"2,765,202","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836603,"accession":"0001209191-07-065219","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-11","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":15.78,"price_display":"15.78","price_state":"stated","total_value":9468.0,"total_display":"9,468.00","total_whole":"9,468","shares_owned_after":2763102.0,"shares_owned_after_display":"2,763,102","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"},{"id":7836594,"accession":"0001209191-07-065219","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001209191-07-065219","line_url":"/filing/0001209191-07-065219#line-10","is_derivative":false,"issuer_cik":"0001314703","issuer_name":"Orexigen Therapeutics, Inc.","issuer_ticker":"OREX","issuer_name_source":null,"issuer_url":"/issuer/0001314703","owner_cik":null,"owner_name":"Scale Venture Partners II, LP; Scale Venture Management II, LLC","owner_display_name":"Scale Venture Partners II, LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":600.0,"shares_display":"600","price_per_share":15.72,"price_display":"15.72","price_state":"stated","total_value":9432.0,"total_display":"9,432.00","total_whole":"9,432","shares_owned_after":2760402.0,"shares_owned_after_display":"2,760,402","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-11-16","filed_date":"2007-11-19","scope":"insider"}],"collapsed":true,"next_cursor":"2007-11-16|7836594","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001375151","name":"ZOGENIX, INC.","url":"/issuer/0001375151","role":"Ten percent owner, Other","n_filings":2,"first_seen":"2010-11-29","last_seen":"2011-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001492426","name":"HORIZON PHARMA, INC.","url":"/issuer/0001492426","role":"Ten percent owner","n_filings":1,"first_seen":"2011-08-04","last_seen":"2011-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Ten percent owner","n_filings":7,"first_seen":"2007-11-16","last_seen":"2007-11-21"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001314703","retrieved_at":"2026-08-22T18:46:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}